Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial

Open access

Abstract

Background Depression is common in dementia but the evidence base for appropriate drug treatment is sparse and equivocal. We aimed to assess efficacy and safety of two of the most commonly prescribed drugs, sertraline and mirtazapine, compared with placebo. Methods We undertook the parallel-group, double-blind, placebo-controlled, Health Technology Assessment Study of the Use of Antidepressants for Depression in Dementia (HTA-SADD) trial in participants from old-age psychiatry services in nine centres in England. Participants were eligible if they had probable or possible Alzheimer's disease, depression (lasting ≥4 weeks), and a Cornell scale for depression in dementia (CSDD) score of 8 or more. Participants were ineligible if they were clinically critical (eg, suicide risk), contraindicated to study drugs, on antidepressants, in another trial, or had no carer. The clinical trials unit at King's College London (UK) randomly allocated participants with a computer-generated block randomisation sequence, stratified by centre, with varying block sizes, in a 1:1:1 ratio to receive sertraline (target dose 150 mg per day), mirtazapine (45 mg), or placebo (control group), all with standard care. The primary outcome was reduction in depression (CSDD score) at 13 weeks (outcomes to 39 weeks were also assessed), assessed with a mixed linear-regression model adjusted for baseline CSDD, time, and treatment centre. This study is registered, number ISRCTN88882979 and EudraCT 2006-000105-38.…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(11)60830-1

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Research works printed but not linked: 1

  1. Bains, 2002, The efficacy of antidepressants in the treatment of depression in dementia, Cochrane Database Syst Rev, 4, CD003944

Cited by

See all 532

Metadata

Authors
Banerjee, S., Hellier, J., Dewey, M., Romeo, R., Ballard, C., Baldwin, R., Bentham, P., Fox, C., Holmes, C., Katona, C., Knapp, M., Lawton, C., Lindesay, J., Livingston, G., McCrae, N., Moniz-Cook, E., Murray, J., Nurock, S., Orrell, M., O'Brien, J., Poppe, M., Thomas, A., Walwyn, R., Wilson, K., & Burns, A.
Affiliations
  • King's College London (GB)
  • University of Manchester (GB)
  • University of Birmingham (GB)
  • University of East Anglia (GB)
  • University of Southampton (GB)
  • University College London (GB)
  • University of Cambridge (GB)
  • University of Leicester (GB)
  • Hull York Medical School (GB)
  • Alzheimer's Society (GB)
  • Newcastle University (GB)
  • University of Liverpool (GB)
Corresponding author
Banerjee, Sube
Venue
The Lancet
Publisher
Elsevier BV
Published
2011-07
Volume
378
Issue
9789
Pages
403-411
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2145846347
Cited by
532
References
41
Citations by year
2026: 14 · 2025: 24 · 2024: 25 · 2023: 16 · 2022: 32 · 2021: 47 · 2020: 25 · 2019: 25 · 2018: 24 · 2017: 41 · 2016: 34 · 2015: 42 · 2014: 50 · 2013: 57 · 2012: 57
FWCI
42.64
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • ePrints Soton (University of Southampton) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Repository@Hull (Worktribe) (University of Hull) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
  • UEA Digital Repository (University of East Anglia) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • American Academy of Neurology
  • National Institute for Health and Care Research (04/11/02)
  • NIHR Evaluation Trials and Studies Coordinating Centre
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
sertraline, mirtazapine, antidepressants, Alzheimer's disease, treatment efficacy, adverse events, older adults, Cornell Scale for Depression in Dementia, anticholinergic effects, serotonin reuptake inhibitors, atypical antidepressants, caregivers, long-term outcomes, health technology assessment, cost-effectiveness, quality of life
MeSH terms
Mirtazapine, Aged, Aged, 80 and over, Alzheimer Disease, Antidepressive Agents, Mental Disorders, Dementia, Depressive Disorder, Double-Blind Method, Female, Humans, Male, Mianserin, Randomized Controlled Trials as Topic, Sertraline

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(11)60830-1
The paper
Banerjee, S., Hellier, J., Dewey, M., Romeo, R., Ballard, C., Baldwin, R., Bentham, P., Fox, C., Holmes, C., Katona, C., Knapp, M., Lawton, C., Lindesay, J., Livingston, G., McCrae, N., Moniz-Cook, E., Murray, J., Nurock, S., Orrell, M., . . . Burns, A. (2011). Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(11)60830-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.